Amendment history : Corrigendum ( March 2018 ) ALX receptor ligands define a biochemical endotype for severe asthma

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of Age and Disease Severity on Systemic Corticosteroid Responses in Asthma

  2017cited by this paper
• Gene Expression Correlated with Severe Asthma Characteristics Reveals Heterogeneous Mechanisms of Severe Disease

  2017cited by this paper
• Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts.

  2016cited by this paper
• Current concepts of severe asthma.

  2016cited by this paper
• Identification of resolvin D2 receptor mediating resolution of infections and organ protection

  2015cited by this paper
• Inflammation activation and resolution in human tendon disease

  2015cited by this paper
• Resolution of acute inflammation in the lung.

  2014cited by this paper
• Pro-resolving lipid mediators are leads for resolution physiology

  2014cited by this paper
• Lipoxin generation is related to soluble epoxide hydrolase activity in severe asthma.

  2014cited by this paper
• Type 2 inflammation in asthma — present in most, absent in many

  2014cited by this paper
• Serum amyloid A inhibits dendritic cell apoptosis to induce glucocorticoid resistance in CD4+ T cells

  2013cited by this paper
• Exhaled breath condensate eicosanoid levels associate with asthma and its severity.

  2013cited by this paper
• Ligand-specific conformational change of the G-protein–coupled receptor ALX/FPR2 determines proresolving functional responses

  2013cited by this paper
• International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

  2013cited by this paper
• Efficacy and safety of 15(R/S)‐methyl‐lipoxin A4 in topical treatment of infantile eczema

  2013cited by this paper
• Lipoxin A4 Regulates Natural Killer Cell and Type 2 Innate Lymphoid Cell Activation in Asthma

  2013cited by this paper
• Serum amyloid A opposes lipoxin A4 to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease

  2012cited by this paper
• Annexin A1 Interaction with the FPR2/ALX Receptor

  2012cited by this paper
• Asthma phenotypes: the evolution from clinical to molecular approaches

  2012cited by this paper
• Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways

  2010cited by this paper
• Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program.

  2010cited by this paper
• FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin‐derived peptide‐stimulated phagocytosis

  2010cited by this paper
• Resolvin E1 regulates interleukin 23, interferon-γ and lipoxin A4 to promote the resolution of allergic airway inflammation

  2008cited by this paper
• Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma.

  2008cited by this paper
• Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism

  2007cited by this paper
• Aspirin-Triggered Lipoxins Override the Apoptosis-Delaying Action of Serum Amyloid A in Human Neutrophils: A Novel Mechanism for Resolution of Inflammation1

  2007cited by this paper
• The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo

  2006influential reference
• Lipoxin A(4) regulates bronchial epithelial cell responses to acid injury.

  2006cited by this paper
• Essential role of STAT3 in cytokine‐driven NF‐κB‐mediated serum amyloid A gene expression

  2005cited by this paper
• Diminished lipoxin biosynthesis in severe asthma.

  2005cited by this paper
• Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound.

  2005cited by this paper
• Future research directions in asthma: an NHLBI Working Group report.

  2004cited by this paper
• Acute phase reactants in allergic airway disease.

  2004cited by this paper
• Aspirin-Triggered Lipoxin A4 and B4 Analogs Block Extracellular Signal-Regulated Kinase-Dependent TNF-α Secretion from Human T Cells 1

  2003cited by this paper
• Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R.

  2003cited by this paper
• Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor

  2002cited by this paper
• Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4

  2002cited by this paper
• Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity

  2002cited by this paper
• Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses.

  2001cited by this paper
• Differential Regulation of Formyl Peptide Receptor-Like 1 Expression During the Differentiation of Monocytes to Dendritic Cells and Macrophages1

  2001cited by this paper
• Activation of Lipoxin a4 Receptors by Aspirin-Triggered Lipoxins and Select Peptides Evokes Ligand-Specific Responses in Inflammation

  2000cited by this paper
• Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion.

  1999cited by this paper
• A Seven-transmembrane, G Protein–coupled Receptor, FPRL1, Mediates the Chemotactic Activity of Serum Amyloid A for Human Phagocytic Cells

  1999cited by this paper
• Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization.

  1996cited by this paper
• Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor

  1994cited by this paper
• The effects of lipoxin A4 on airway responses in asthmatic subjects.

  1992cited by this paper
• Identification of lipoxin A4 and its relationship to the sulfidopeptide leukotrienes C4, D4, and E4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases.

  1990cited by this paper

• Quantitative proteomics profiling of plasma from children with asthma.

  2023cites this paper
• Mast cells contribute to the resolution of allergic inflammation by releasing resolvin D1.

  2023cites this paper
• In vitro neutrophil migration is associated with inhaled corticosteroid treatment and serum cytokines in pediatric asthma

  2022cites this paper
• Potential role of lipoxin in the management of COVID-19: a narrative review

  2022cites this paper
• Macrophage migration inhibitory factor promotes glucocorticoid resistance of neutrophilic inflammation in a murine model of severe asthma

  2022cites this paper
• Lipoxin alleviates oxidative stress: a state-of-the-art review

  2022cites this paper
• Latest Progresses in Allergic Diseases Biomarkers: Asthma and Atopic Dermatitis

  2021cites this paper
• Serum Neutrophil Gelatinase-associated Lipocalin (NGAL) Is Elevated in Patients with Asthma and Airway Obstruction

  2021cites this paper
• Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium

  2020cites this paper
• Intersection of biology and therapeutics: type 2 targeted therapeutics for adult asthma.

  2020cites this paper
• Serum amyloid A is a soluble pattern recognition receptor that drives type 2 immunity

  2020cites this paper
• Therapeutic Efficacy of IL-17A Neutralization with Corticosteroid Treatment in a Model of Antigen-Driven Mixed Granulocytic Asthma.

  2020cites this paper
• Responsiveness to Parenteral Corticosteroids and Lung Function Trajectory in Adults with Moderate to Severe Asthma.

  2020cites this paper
• Severe asthma phenotypes and endotypes.

  2019cites this paper
• Activation of Resolution Pathways to Prevent and Fight Chronic Inflammation: Lessons From Asthma and Inflammatory Bowel Disease

  2019cites this paper
• Non-type 2 inflammation in severe asthma is propelled by neutrophil cytoplasts and maintained by defective resolution.

  2019cites this paper
• Specialized Proresolving Mediators in Innate and Adaptive Immune Responses in Airway Diseases.

  2018cites this paper
• Crosstalk Between Alveolar Epithelial Cells and Macrophages in Asthma

  2018cites this paper
• The Matter of the Lung: Quantification of Vascular Substance in Asthma.

  2018cites this paper